These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27280389)

  • 21. Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update.
    Lehrnbecher T; Robinson P; Fisher B; Alexander S; Ammann RA; Beauchemin M; Carlesse F; Groll AH; Haeusler GM; Santolaya M; Steinbach WJ; Castagnola E; Davis BL; Dupuis LL; Gaur AH; Tissing WJE; Zaoutis T; Phillips R; Sung L
    J Clin Oncol; 2017 Jun; 35(18):2082-2094. PubMed ID: 28459614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention and treatment of invasive fungal diseases in neutropenic patients.
    Almyroudis NG; Segal BH
    Curr Opin Infect Dis; 2009 Aug; 22(4):385-93. PubMed ID: 19506476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current research in empirical therapy for febrile neutropenia in cancer patients: what should be necessary and what is going on.
    Castagnola E; Mikulska M; Barabino P; Lorenzi I; Haupt R; Viscoli C
    Expert Opin Emerg Drugs; 2013 Sep; 18(3):263-78. PubMed ID: 23777534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Empirical antifungal therapy in patients with febrile neutropenia].
    Nucci M
    Drugs Today (Barc); 2010 Apr; 46 Suppl C():13-20. PubMed ID: 20490378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk Factors for Invasive Fungal Infection among Thai Oncologic Patients with Febrile Neutropenia and Cutaneous Presentation: A 5-Year Retrospective Study in Southern Thailand.
    Aiempanakit K; Naorungroj S; Chiratikarnwong K; Auepemkiate S; Apinantriyo B
    Asian Pac J Cancer Prev; 2017 Dec; 18(12):3239-3243. PubMed ID: 29286213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials.
    Bow EJ; Laverdière M; Lussier N; Rotstein C; Cheang MS; Ioannou S
    Cancer; 2002 Jun; 94(12):3230-46. PubMed ID: 12115356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.
    Maertens J; Theunissen K; Verhoef G; Verschakelen J; Lagrou K; Verbeken E; Wilmer A; Verhaegen J; Boogaerts M; Van Eldere J
    Clin Infect Dis; 2005 Nov; 41(9):1242-50. PubMed ID: 16206097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive fungal infections in AML/MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis?
    Pomares H; Arnan M; Sánchez-Ortega I; Sureda A; Duarte RF
    Mycoses; 2016 Aug; 59(8):516-9. PubMed ID: 27027972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Empiric vs. preemptive antifungal treatment: an appraisal of treatment strategies in haematological patients.
    Rieger CT; Ostermann H
    Mycoses; 2008; 51 Suppl 1():31-4. PubMed ID: 18471159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wait and see or rush and switch? New questions for the management of patients with febrile neutropenia receiving antifungal prophylaxis.
    Karthaus M; Hentrich M
    Mycoses; 2011 Jan; 54 Suppl 1():1-6. PubMed ID: 21126265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Empirical antifungal therapy in febrile neutropenic patients: current status.
    Kibbler CC
    Curr Top Med Mycol; 1997 Dec; 8(1-2):5-14. PubMed ID: 9504062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations of Antifungal Treatments With Prevention of Fungal Infection in Critically Ill Patients Without Neutropenia.
    Cortegiani A; Russotto V; Giarratano A
    JAMA; 2017 Jan; 317(3):311-312. PubMed ID: 28114533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode.
    Demirel A; Tabak F; Ar MC; Mete B; Öngören Ş; Yemişen M; Özaras R; Eşkazan E; Başlar Z; Mert A; Soysal T; Ferhanoğlu B; Aydın Y; Öztürk R
    Turk J Haematol; 2015 Sep; 32(3):243-50. PubMed ID: 25913035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there a role for glutamine supplementation in the management of acute pancreatitis?
    Castro-Gutiérrez V; Rada G
    Medwave; 2016 Aug; 16 Suppl 3():e6512. PubMed ID: 27580296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Executive Summary of Japanese Domestic Guidelines for Management of Deep-seated Mycosis 2014.
    Kohno S; Tamura K; Niki Y; Izumikawa K; Oka S; Ogawa K; Kadota J; Kamei K; Kanda Y; Kiuchi T; Shibuya K; Takakura S; Takata T; Takesue Y; Teruya K; Tokimatsu I; Fukuda T; Maesaki S; Makimura K; Mikamo H; Mitsutake K; Miyazaki Y; Mori M; Yasuoka A; Yano K; Yamanaka N; Yoshida M
    Med Mycol J; 2016; 57(4):E117-E163. PubMed ID: 27904053
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prophylactic and empirical treatment of mycoses in neutropenic fever. Report and comments on meta-analysis].
    Kalin M; Björkholm M
    Lakartidningen; 2001 Apr; 98(16):1899-903. PubMed ID: 11370406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Empirical antifungal treatment: a valid alternative for invasive fungal infection.
    Vallejo C; Barberán J
    Rev Esp Quimioter; 2011 Sep; 24(3):117-22. PubMed ID: 21947092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of fungal infections in the immunocompromised host.
    Mahfouz T; Anaissie E
    Curr Opin Investig Drugs; 2003 Aug; 4(8):974-90. PubMed ID: 14508882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Empirical antifungal therapy in treating febrile neutropenic patients.
    Wingard JR
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S38-43. PubMed ID: 15250019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical hepatotoxicity associated with antifungal agents.
    Kyriakidis I; Tragiannidis A; Munchen S; Groll AH
    Expert Opin Drug Saf; 2017 Feb; 16(2):149-165. PubMed ID: 27927037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.